LRHB 28 FRB: LR Health & Beauty SE Celebrates Successful 2023, Unveils Innovative Products

• LR Health & Beauty SE reported a successful 2023 financial year with sales increasing to EUR 276.5 million, a 3% increase year-over-year despite negative currency effects.
• The company achieved a normalized EBITDA of EUR 35.4 million in 2023, with EBITDA reported increasing to EUR 31.4 million compared to the previous year’s figure of EUR 31.1 million.
• LR Health & Beauty SE expanded its innovative product range, including successful launches of BODY MISSION and Mind Master Gold, contributing to the company's strong performance in 2023.
• The company is focusing on further digitalisation of business processes and has established a centralised platform, LR neo sales platform, for partners to make their business processes more efficient.
• For 2024, the company plans to continue expanding its innovative product portfolio and expects sales to remain at last year’s level despite the good start to the year, and a slightly lower or stable EBITDA.
• The complete 2023 Annual Report and the Sustainability Report 2023 are available online on the company's website.

The price of LRHB 28 FRB at the time of the news was 95,03EUR and was down -0,04 % compared with the previous day.
29 minutes after the article was published, the price was 95,07EUR this corresponds to a plus of +0,04 % since publication.

LRHB 28 FRB

0,00 %

-0,61 %

+0,09 %

-0,59 %

ISIN:NO0013149658WKN:A3513A

• Intraday
• 5 Tage
• 1 Monat
• Max